Patents by Inventor James R. Matson

James R. Matson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
    Publication number: 20010051106
    Abstract: A hemofiltration system for a mammal comprises a hemofilter and an adsorbent device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorbent device is comprised of one or more adsorbent materials and is used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter removing inflammatory mediators that cause inflammatory mediator related disease, sepsis, and SIRS/MODS/MOSF to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream is selectively combined with the filtered blood stream and together with the filtered blood stream is returned to the mammal.
    Type: Application
    Filed: July 25, 2001
    Publication date: December 13, 2001
    Applicant: Immunocept, L.L.C.
    Inventors: James R. Matson, Patrice A. Lee
  • Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
    Patent number: 6287516
    Abstract: A hemofiltration system for a mammal comprises a hemofilter and an adsorbent device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorbent device is comprised of one or more adsorbent materials and is used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter removing inflammatory mediators that cause inflammatory mediator related disease, sepsis, and SIRS/MODS/MOSF to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream is selectively combined with the filtered blood stream and together with the filtered blood stream is returned to the mammal.
    Type: Grant
    Filed: July 10, 1998
    Date of Patent: September 11, 2001
    Assignee: Immunocept, L.L.C.
    Inventors: James R. Matson, Patrice R. Lee
  • Hemofiltration of toxic mediator-related disease
    Patent number: 5571418
    Abstract: The present invention provides methods of treating pathophysiological states characterized by the presence in blood of certain toxic mediators. The novel method of hemofiltration of the present invention provides an effective treatment of several such disease including sepsis, shock, acute renal failure, multiple organ system failure and systemic inflammatory response syndrome-related diseases.
    Type: Grant
    Filed: July 6, 1994
    Date of Patent: November 5, 1996
    Inventors: Patrice A. Lee, James R. Matson, Robert W. Pryor